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What is already known about the topic? 
x Internationally, stakeholder (i.e. lay people and professionals with an interest in the topic) 
involvement in research and Health Technology Assessment (HTA) is advocated. Stakeholder 
involvement has the potential to ensure key shared priorities are addressed and research findings 
translated into practice.  
x The philosophy and views about the best approaches for stakeholder involvement differ across 
Europe. Stakeholder consultation is seen as one of the most appropriate approaches to involvement 
in some countries. However, qualitative research is viewed as the most appropriate method of 
stakeholder involvement in other European countries.   
x Few reports exist about stakeholder involvement in palliative care and the ways this informs decision 
making in HTA. 
What this paper adds? 
x This paper demonstrates that it is possible to involve lay (e.g. patients/ex-patients; family carers/ex-
carers; family members and members of public organisations or groups ?and professional (e.g. ƐĞƌǀŝĐĞ
ĐŽŵŵŝƐƐŝŽŶĞƌƐ ?ŚĞĂůƚŚĂŶĚƐŽĐŝĂůĐĂƌĞƉƌŽĨĞƐƐŝŽŶĂůƐ ?ĂĐ ĚĞŵŝĐƐǁŽƌŬŝŶŐŝŶƉĂůůŝĂƚŝǀĞĐĂƌĞ ? 
stakeholders in HTA.  
x Several approaches to stakeholder involvement in palliative care research are shown to be feasible 
and effective ways to identify stakeholder priorities. 
x Despite the use of different methods of stakeholder involvement, stakeholders highlight a number of 
issues in palliative care that are  ‘ĐŽŵŵŽŶ ‘ĂĐƌŽƐƐ countries.  The researchers used the issues raised to 
inform decision making for project development. Notably the issues raised informed the focus of the 
main HTA question and sub questions used in the assessment of specific aspects.  
Implications for practice, theory or policy? 
x Different methods of stakeholder involvement may be required for different palliative care 
stakeholder groups in different countries.  
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x Lay and professional stakeholder involvement is both feasible and worthwhile early in project 
development as this can identify key issues from the perspectives of service users and providers. 
x Further guidance for stakeholder involvement in palliative care research is needed to ensure that 
policy and service development is more responsive to the needs of service users and providers.  
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Abstract 
ĂĐŬŐƌŽƵŶĚ ?^ƚĂŬĞŚŽůĚĞƌƐĂƌĞpeople with an interest in the topic.Internationally, stakeholder involvement in 
palliative care research and Health Technology Assessment requires -development  Stakeholder involvement 
adds value throughout research (from prioritizing topics to disseminating findings).Philosophies and 
understandings about the best ways to involve stakeholders in research differ across Europe. ^takeholder 
involvement took place  in seven European countries (England, Germany, Italy, Lithuania, The Netherlands, 
Norway and Poland) to inform a project that developed concepts and methods for HTA and applied these to 
evaluate models of palliative care service delivery. 
ŝŵƐ ?dŽƌĞƉŽƌƚŽŶƐƚĂŬĞŚŽůĚĞƌŝŶǀŽůǀĞŵĞŶƚĂƐƉĂƌƚŽĨƚŚĞ/Ed'Zd-,dƉƌŽũĞĐƚand howkey issues 
identified informed project development. 
ĞƐŝŐŶ ?hsing stakeholder consultation or a qualitative research design, stakeholders in seven countries acted 
as  ‘advisors ?ƚŽĂŝĚƌĞƐĞĂƌĐŚĞƌƐ ?ĚĞĐŝƐŝŽŶmaking. TŚĞŵĂƚŝĐĂŶĂůǇƐŝƐǁĂƐƵƐĞĚƚŽŝĚĞŶƚŝĨǇŬĞǇŝƐƐƵĞƐĂĐƌŽƐƐ
ĐŽƵŶƚƌŝĞƐ ? 
Setting/participants: 132 ƐƚĂŬĞŚŽůĚĞƌƐ ? ? ?ƉƌŽĨĞƐƐŝŽŶĂůƐĂŶĚ ? ? ‘ůĂǇ ?ƉĞŽƉůĞ ?ĂŐĞĚA? ? ?ƉĂƌƚŝĐŝƉĂƚĞĚŝŶ
ŝŶĚŝǀŝĚƵĂůĨĂĐĞ-ƚŽ-ĨĂĐĞŽƌƚĞůĞƉŚŽŶĞŝŶƚĞƌǀŝĞǁƐ ?ĐŽŶƐƵůƚĂƚŝŽŶŵĞĞƚŝŶŐƐŽƌĨŽĐƵƐŐƌŽƵƉƐ ? 
ZĞƐƵůƚƐ ?Different methods of stakeholder involvement were used successfully to identify key issues in 
palliative care. Twenty-three issues common to three or more countries informed decisions about the 
intervention and comparator of interest; sub questions and specific assessments within the HTA.  
ŽŶĐůƵƐŝŽŶƐ ?^ƚĂŬĞŚŽůĚĞƌƐĐĂŶŝŶĨŽƌŵƉƌŽũĞĐƚĚĞĐŝƐŝŽŶŵĂŬŝŶŐƵƐŝŶŐĂǀĂƌŝĞƚǇŽĨŵĞƚŚŽĚƐŽĨŝŶǀŽůǀĞŵĞŶƚ ?
Researchers should consider local ƵŶĚĞƌƐƚĂŶĚŝŶŐƐĂďŽƵƚƐƚĂŬĞŚŽůĚĞƌŝŶǀŽůǀĞŵĞŶƚwhen undertaking this as 
ǀŝĞǁƐŽĨĂƉƉƌŽƉƌŝĂƚĞĂŶĚĨĞĂƐŝďůĞŵĞƚŚŽĚƐǀĂƌǇ ? Methods for stakeholder involvement, especially 
consultation, need further development. 
 
Keywords: Patient Involvement, palliative care, Health Technology Assessment    
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Introduction 
Stakeholder involvement aims to gain the views and perspectives of stakeholders to inform research and HTA. 
Stakeholders include professionals (e.g. service commissioners, professionals and academics) and lay people 
(e.g. service users and their family carers). Internationally, the need for stakeholder involvement in palliative 
care research has been recognized
1. 
Although published examples of lay stakeholder involvement in palliative 
care research exist
2
, several barriers including a lack of time, available funds, clarity and specificity about the 
role of public involvement in research
2
 need to be overcome. 
 
 
 
Stakeholder involvement, including patient involvement, is established in Health Technology Assessment (HTA) 
as many groups have a legitimate interest in the outcome of HTA projects
3
. HTA research informs health policy 
decision making to ensure best value for money
4
. HTA uses a multidisciplinary approach to systematically and 
transparently assess the cost and clinical effectiveness, safety, organizational, ethical, legal and social issues of 
health technologies (e.g. medicines, devices, procedures and health care services)
4
.  There is increasing 
recognition of the need for HTA to assess complex health technologies
5
 which are imperative in dealing with 
the rise in numbers of people with chronic diseases.Incrementally changing, context dependent palliative care 
services are a good example of a complex technology
6
. ,ŽǁĞǀĞƌ ?ƚŚĞƌĞŝƐa need to determine which models of 
palliative care service provision are most effective to inform future health policy and service decision making
7
. 
This is especially important as models of palliative care service provision across Europe are developing in 
various ways (reflecting the different cultures, religious beliefs and legal frameworks that exist)
8
.  
 
Palliative care research in the context of Health Technology Assessment (HTA) is still in its infancy. Hence, 
whilst knowledge and experience of stakeholder involvement is growing in a number of fields
2,9
, further 
guidance relating specifically to stakeholder involvement in palliative care research and HTA is needed.  This is 
particularly important as the usefulness and utilization of HTA depend on stakeholder involvement
3
. 
 
Despite recognition that stakeholder involvement is important in HTA, some hesitancy exists about how much 
influence stakeholders should have on scientific processes
3
. Furthermore, the extent and methods used for 
stakeholder involvement varies according to national and regional needs and traditions
3
. Indeed, the 
philosophy and understandings about the most appropriate ways to involve stakeholders (especially patients 
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and the public) in research differs across Europe. For example, INVOLVE, a U.K.ŶĂƚŝŽŶĂůĂĚǀŝƐŽƌǇŐƌŽƵƉǁĂƐƐĞƚ
ƵƉƚŽƐƵƉƉŽƌƚƉƵďůŝĐŝŶǀŽůǀĞŵĞŶƚ(i.e. patients, carers and those using health and social services)ŝŶEĂƚŝŽŶĂů
,ĞĂůƚŚ^ĞƌǀŝĐĞ ?E,^ ? ?ƉƵďůŝĐŚĞĂůƚŚĂŶĚƐŽĐŝĂůĐĂƌĞƌĞƐĞĂƌĐŚ10, although such mechanisms are not evident 
elsewhere in Europe. INVOLVE differentiate between public involvement, participation and engagement in 
research (see box 1). INVOLVE suggest stakeholder consultation (i.e. asking people their views) is one approach 
to involvement that can inform decision making in research
10
.  However, qualitative research is advocated as 
the best approach to stakeholder involvement in several countries across Europe, although no specific 
methodology is recommended.   
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Box 1: Examples of involvement, participation and engagement.  
 
  ‘/ŶǀŽůǀĞŵĞŶƚ ? 
 
People are actively involved in research projects and in research organisations. 
Approaches to stakeholder involvement include: 
i) consultation (seeking stakeholder views to influence researcher decision 
making);  
ii)collaboration (researchers and stakeholders share decision making throughout 
the study) or  
iii) user-controlled research (stakeholders direct the research). 
 
 
 ‘WĂƌƚŝĐŝƉĂƚŝŽŶ ? People takepart in a research study by providing data (e.g. in surveys or 
qualitative research interviews).  
 
 
 ‘ŶŐĂŐĞŵĞŶƚ ? Information and knowledge about research is provided and disseminated by 
researchers. 
 
Source: INVOLVE (2012 p.7)  
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An opportunity to involve palliative care stakeholders presented itself in the context of a large European 
project (INTEGRATE-HTA)
 
(see http://www.integrate-hta.eu/.) The INTEGRATE-HTA project developed 
concepts and methods for the integrated assessment of complex technologies as policy-makers need better 
tools to support their decision making regarding complex health technologies
11
. To demonstrate their 
feasibility and value, concepts and methods developed in the project were applied in a case study using 
models of palliative care service delivery as an example of a complex technology. As palliative care provision 
differs throughout Europe, the case study was undertaken in England for pragmatic reasons. At the outset of 
the INTEGRATE-HTA project, we wanted to identify key issues in palliative care in all participating countries to 
ensure that the project findings may have relevance to more than one country.  Hence, we collected 
ƐƚĂŬĞŚŽůĚĞƌƐ ?ƉĞƌƐƉĞĐƚŝǀĞƐ about key issues and topics of importance for palliative care as one way of involving 
ƐƚĂŬĞŚŽůĚĞƌƐĂŶĚŝŶĨůƵĞŶĐŝŶŐƌĞƐĞĂƌĐŚĞƌƐ ?ĚĞĐŝƐŝŽŶŵĂŬŝŶŐthroughout the project. A separate paper is being 
developed to report on the extensive stakeholder involvement that occurred throughout the project. 
Aim 
dŚŝƐƉĂƉĞƌƌĞƉŽƌƚƐŽŶƐƚĂŬĞŚŽůĚĞƌŝŶǀŽůǀĞŵĞŶƚŝŶƐĞǀĞŶƵƌŽƉĞĂŶĐŽƵŶƚƌŝĞƐĂƐƉĂƌƚŽĨ the INTEGRATE-HTA 
project.  
Methods  
Design & settings 
>ĂǇĂŶĚƉƌŽĨĞƐƐŝŽŶĂůƉĂůůŝĂƚŝǀĞĐĂƌĞƐƚĂŬĞŚŽůĚĞƌƐŝŶƐĞǀĞŶƵƌŽƉĞĂŶĐŽƵŶƚƌŝĞƐĂĐƚĞĚĂƐ  ‘advisors ? to inform 
project development from an early stage.  Ɛ ‘ĂĚǀŝƐŽƌƐ ? ?ƐƚĂŬĞŚŽůĚĞƌƐƉƌŽǀŝĚĞĚŝŶĨŽƌŵĂƚŝŽŶŽƌĚĂƚĂƚŚĂƚ
ŝŶĨŽƌŵĞĚƌĞƐĞĂƌĐŚĞƌƐ ?ĚĞĐŝƐŝŽŶŵĂŬŝŶŐŝŶƚŚĞproject ? An experienced HTA researcher or palliative care 
clinician was appointed to be a local co-ordinator in each country. Local co-ordinators were given a guide to 
assist in establishing some consistency in planning stakeholder involvement, including example documentation 
(e.g. information sheets, consent forms). Additional guidance was given by the wider project team based on 
their knowledge of methodologically and contextually appropriate methods for each country. Methodological 
details are reported in tables 1, 2 and 3. As stakeholder involvement to assist project development in HTA is 
novel
14
 and palliative care is a complex and culturally sensitive topic
6
, a local co-ordinator conducted 
stakeholder meetings in each country. The local co-ordinator was a member of the research team or their 
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known associates, some of whom were experienced in palliative care research and others were HTA 
researchers. The local co-ordinator ensured that adequate support was available for stakeholders taking part 
in the project (e.g. ensuring an additional facilitator was available or allowing relatives to be present in 
meetings / interviews in case stakeholders became distressed). The local co-ordinator selected appropriate 
methods and arranged and / or conducted stakeholder meetings based on what is considered best practice for 
stakeholder involvement and palliative care in their own country. Across the seven countries, two approaches 
to stakeholder involvement were used; stakeholder consultation or a qualitative research approach. 
1) Stakeholder consultation: Local co-ordinators in ŶŐůĂŶĚ ?EŽƌǁĂǇĂŶĚWŽůĂŶĚ ĂĚŽƉƚĞĚ ƚŚĞh ?< ? ?ƐƉŚŝůŽƐŽƉŚǇ
ĨŽƌůĂǇƐƚĂŬĞŚŽůĚĞƌŝŶǀŽůǀĞŵĞŶƚĂŶĚĂůůƐƚĂŬĞŚŽůĚĞƌƐǁĞƌĞĐŽŶƐƵůƚĞĚĂƐ ‘ƌĞƐĞĂƌĐŚĂĚǀŝƐŽƌƐ ?ƚŽŝŶĨŽƌŵ
ƌĞƐĞĂƌĐŚĞƌƐ ?ĚĞĐŝƐŝŽŶŵĂŬŝŶŐŝŶƚŚĞ project ?Consultations were guided by the National Institute for Health and 
Care Excellence (NICE) (2012) methods for developing public health guidance
15
 and the INVOLVE (2012) 
briefing notes for involving the public in research
2
. Information was collected and summarised using the 
EUnetHTA Core Model ®
14
 as an overarching framework (See Table 2).  
2) Qualitative research: A variety of qualitative approaches were ƵƐĞĚŝŶĨŽƵƌĐŽƵŶƚƌŝĞƐ(Germany, Italy, The 
Netherlands and Lithuania) according to local tradition and researcher preference about stakeholder 
involvement ? These included nominal group technique16 and categorical coding procedure following Grounded 
Theory methodology by Strauss and Corbin (1990)
17
; interactive evaluation and subsequently case 
reconstruction using constant comparison
18 
and thematic analysis
19
(see Table 3). 
Ethical approval  
Ethical approval requirements varied in each country. Where needed, local co-ordinators ensured that 
appropriate ethical approval was secured prior to stakeholder involvement. In England stakeholders were 
involved as advisors and therefore ethical approval was not required in keeping with the National Research 
Ethics Service (NRES) and INVOLVE (2009) joint statement
23
. In Lithuania, permission was obtained from the 
Director of the Hospice and verbal consent was subsequently obtained from participants. In the Netherlands, 
the ethics committee waived ethics approval for stakeholder discussions. In Poland, ethical approval was 
obtained for the meeting with family members.  Ethical approval was granted from the respective committees 
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in Germany, Italy and all relevant institutions in Norway. In all countries, stakeholders received a letter and 
information sheet prior to taking part in the project.  Oral and written consent was gained in all countries. 
Stakeholders 
Recognising different types of stakeholder expertise, both professionals and lay people ǁĞƌĞŝŶǀŝƚĞĚƚŽ
ƉĂƌƚŝĐŝƉĂƚĞ ?dŚĞĂŝŵǁĂƐƚŽĞŶƐƵƌĞǀĂƌŝĂƚŝŽŶŝŶĂĚǀŝƐŽƌƐ ?ƐƚĂƚƵƐĂŶĚŚĞĂůƚŚĐĂƌĞƐĞƚƚŝŶŐƐ ?ƚŚƵƐƉƌŽǀŝĚŝŶŐĂ ‘ǀŽŝĐĞ ?
ĨŽƌĂƐŵĂŶǇƐƚĂŬĞŚŽůĚĞƌƐĂƐƉŽƐƐŝďůĞ ?ƚŽƚĂůŽĨ ? ? ?ƐƚĂŬĞŚŽůĚĞƌƐ ? ? ?ƉƌŽĨĞƐƐŝŽŶĂůƐĂŶĚ ? ? ‘ůĂǇ ?ƉĞŽƉůĞ ?aged 18 
and over were recruited across the seven countries; (see Table 4).  Most stakeholders were female (n=90) and 
(where known), white Christians.  
Working with stakeholders 
Researchers in each country, with varying experience of palliative care and of working with stakeholders, 
undertook work with stakeholders in their native language between May 2013 and June 2014 ?there possible, 
researchers with experience of talking to patients with palliative care needs conducted meetings and 
interviews.  
All stakeholders were well enough to take part in the project without any special arrangements being made.  
However, care was taken not to overtire stakeholders, especially patients and carers. Patients could have 
relatives or carers present in the meeting / interview if they wished, although none took up this opportunity. 
Additional staff (i.e. an administrator) attended some meetings to provide support in meetings.  Various 
mechanisms were used to feedback to stakeholders, including; sending them  a summary of the information 
they provided for verification of the issues raised and/or feeding back to stakeholders at subsequent meetings 
( some lay stakeholders participated in bi annual advisory meetings throughout the project in England).    
Stakeholder consultation 
See Table 1 for more details of methods used in England, Norway and Poland. Palliative care experts identified 
stakeholders. An adapted version of the EUnetHTA core model
14
  domains  (with some example questions for 
the assessment elements) (see Table 2) provided a comprehensive structure that guided individual or small 
group face-to-face or telephone discussions with all stakeholders. The adaptations involved specifically seeking 
advice about palliative care when asking about each domain and seeking stakeholder views about 
Brereton et al                                 
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heterogeneity and patient preferences. One or two questions were prepared relating to assessment elements 
for each domain in case a prompt was required (see Table 2). However, these questions were usually not 
required as the domĂŝŶŚĞĂĚŝŶŐƐƉƌŽǀĞĚƐƵĨĨŝĐŝĞŶƚƚŽƐƚŝŵƵůĂƚĞ ‘ĨƌĞĞ-ĨůŽǁŝŶŐ ?ĚŝƐĐƵƐƐŝŽŶŽĨŬĞǇŝƐƐƵĞƐĂĐƌŽƐƐ
domains. Audio recordings were transcribed and/or notes (all anonymised) were written up after each 
meeting. Each local co-ordinator undertook analysis to identify key issues within each of the EUnetHTA Core 
Model®
14
 domains.  
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Table 1. Methods used in England, Norway and Poland. 
Methods Used  England  ? lay stakeholders England  ? Professionals  Norway  ? lay stakeholders Norway  ? Professionals   Poland  ? lay stakeholders Poland- Professionals   
Location:  Sheffield  W a city in the North 
of England  
From across England & 1 
from Ireland (with 
experience of working in 
England) 
Oslo Oslo Bydgoszcz Bydgoszcz 
Approach used  Consulting  stakeholders 
 
Consulting  stakeholders 
 
Consulting  stakeholders 
 
Methods used to identify & 
approach stakeholders  
The co-ordinator (LB ± some 
experienced in palliative 
care research) directly 
approaching lay advisory 
groups from information 
provided by local experts on 
the INTEGRATE-HTA project 
team members. 
 
 
The co-ordinator (LB) directly 
approaching individuals & 
managers of organizations 
from information provided 
by local experts on the 
INTEGRATE-HTA project team 
members.  
  
A contact person from a 
palliative care unit assisted 
with the recruitment of 
patients and relatives as 
advisors.   
The co-ordinator (KBL - an 
HTA researcher) directly 
approached a key person and 
Professor in Palliative 
medicine who nominated a 
colleague to attend. They 
then suggested other 
professionals.  
The co-ordinator (WL  W a 
palliative care expert) 
directly approaching 
individual or organizations. 
The co-ordinator (WL W a 
palliative care expert) 
directly approaching 
individual or organizations. 
One professional approached 
the co-ordinator having 
heard about the study via the 
INTEGRATE-HTA newsletter. 
Number of advisors & Total 
No. of meetings (Group / 
individual / both used) 
20 patient advisors who are 
members of 2 established 
patient groups were involved 
in a total of 5 Individual and 
group meetings (1x 10; 1x5; 
2x2 & 1x1)  
34 professionals took part in 
individual and small group 
(up to 3 people) meetings 
(n=-22 - including a pilot with 
3 academic experts from 
INTEGRATE-HTA project).  
 
5 lay advisors took part in a 
total of 4 Individual and 
Group Meeting (1 with the 
patient and relative together)  
5 professional experts took 
part in 2 group meetings.  
8 participants  W all members 
of societies or volunteers, no 
patients took part in one 
group meeting.  
7 professional experts took 
part in one group meeting. 
information collection 
methods  
& /ŶƚĞƌǀŝĞǁĞƌ ?ƐƌĞůĂƚŝŽŶƐŚŝƉ
with participants 
One-off meetings using the EUnetHTA Core Model®
14
 domains 
as a discussion guide. 
LB, at the time unknown to most stakeholders, facilitated all 
meetings.  A female administrator took notes at some lay 
stakeholder meetings. 
One-off meetings using the EUnetHTA Core Model®
14
 domains 
as a discussion guide. 
KBL, at the time unknown to stakeholders, facilitated all 
meetings.   
 
One-off meetings using the EUnetHTA Core Model®
14
 domains 
as a discussion guide. 
WL, at the time known to most stakeholders, facilitated all 
meetings.   
Face-to-face  / telephone / 
other  
Face-to-face. Face-to-face and telephone. Face-to-face.  Face-to-face.  Face-to-face   Face-to-face. 
Audio recorded / notes taken  Notes taken 
 
Some  were audio-recorded 
& notes were taken  
 
Some  were audio-recorded 
and notes were take 
Notes taken Audio recorded and notes 
taken 
Audio recorded and notes 
taken 
Setting for meeting   W e.g. 
home office etc.  
A University building. University offices or the 
ĂĚǀŝƐŽƌƐ ?ǁŽƌŬƉůĂĐĞ ?
WĞƌƐŽŶ ?ƐŚŽŵĞ ?ĞǆĐĞƉƚŽŶĞ
which was held at the 
hospital.  
All meetings took place in the 
ĂĚǀŝƐŽƌƐ ?ǁŽƌŬƉůĂĐĞ ? 
Hospice in  Bydgoszcz Hospice in  Bydgoszcz 
Duration of meeting 45 minutes to 75 minutes.  
 
60 minutes to 105 minutes.  
 
Approximately 45 minutes. Approximately 1 hour.  120 minutes 120 minutes 
Methods used to analyse 
information  
Anonymised advice was organised using the EUnetHTA Core 
Model®
14
  as an overarching  framework by  LB 
Anonymised advice was organised using the EUnetHTA Core 
Model®
14
  as an overarching  framework by  KBL 
Anonymised advice was organised using the EUnetHTA Core 
Model®
14
  as an overarching  framework by WL 
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Table 2. Adaptions to the EUnetHTA Core Model®
14
. 
Domains of the EUnetHTA 
Core Model ®
14
:  
Adapted version used in stakeholder consultations included example 
questions to stimulate discussion using some assessment elements 
1. Health problem and 
current use of the technology 
(implementation level)  
 
Health problem and current use of palliative care (the technology) 
x What are the most important health problems that palliative 
care may help? 
x What palliative care services are available locally and 
nationally? 
2. Description and technical 
characteristics of technology  
Description of technical characteristics of palliative care (the technology) 
x What aspects of palliative care are most useful? 
3. Safety  
 
Safety  
x What types of harm may palliative care do? (These may be 
direct or indirect harms) 
x What safety issues need considering with palliative care? 
4. Clinical effectiveness  
 
Clinical Effectiveness 
x What are the health benefits of palliative care? 
x What aspects of palliative care work well? 
5. Costs and economic 
evaluation  
 
Cost Effectiveness 
x How should we pay for palliative care services? 
6. Ethical analyses 
 
Ethical aspects ʹ e.g. Fairness, equity, access, autonomy, human rights. 
x What ethical concerns arise about palliative care? 
7. Organisational aspects  
 
Organisational aspects (Resources required, delivery / work processes, 
organisational culture, staffing, access, funding.)  
x How can palliative care best be organised? 
8. Social aspects  
 
Social aspects Lifestyle - work, family life, leisure time, religious, other 
activitie 
x What social impact does palliative care have on the lives of 
patients, their family and carer? 
9. Legal aspects  
 
Legal aspects 
x What legal issues are important considerations in palliative 
care? 
 
Heterogeneity (differences) 
 
x Heterogeneity (differencesWhat differences in people or 
circumstances may affect the usefulness of palliative care? 
 
Preferences 
 
Preferences 
x What preferences should be taken into account when using 
palliative care? 
 x Is there any other aspect of palliative care that you would like to 
comment on? 
 
  
14                                                                                                                               Palliative Medicine 0(0) 
 
Qualitative research approach 
See Table 3 for more details of methods used in Germany, Italy, The Netherlands and Lithuania, where 
procedures were undertaken in accordance with the qualitative research methodologies selected. 
Convenience and purposive sampling strategies were used
21
 along with face-to-face data collection. In The 
Netherlands and Italy, individual interviews were completed; the latter were guided by the EUnetHTA Core 
Model®
14
.. In Germany, individual interviews were used with patients and focus groups with relatives and 
professionals. In Lithuania, focus groups and one individual interview were conducted with professionals, 
some of whom were representing patient organisations.  Discussions were either audio recorded and/ or notes 
were taken. Audio recordings were transcribed and notes were written up after each meeting. Co-ordinators 
undertook analysis as appropriate for their qualitative approach
20
.  
Synthesising the findings from all stakeholders  
There is an absence of evidence based guidance on synthesising findings across different qualitative and 
stakeholder consultation paradigms. As the project developed concepts and methods for HTA, we used the 
EUnetHTA Core Model®
14
 domains to structure the findings from stakeholder involvement in an attempt to 
identify issues that could inform as many HTA assessment aspects and sub questions as possible. Therefore, a 
table listing the key issues within each of the EUnetHTA Core Model®
14
 domains was developed and populated 
with the results from each of the seven countries (see Table 5). The list of issues was clustered into four broad 
 ‘ƚŚĞŵĞƐ ?ƵƐŝŶŐĂŶĂƉƉƌŽĂĐŚŐƵŝĚĞĚďǇƚŚĞŵĂƚŝĐĂŶĂůǇƐŝƐŝŶ ƋƵĂůŝƚĂƚŝǀĞƌĞƐĞĂƌĐŚ20. This approach was 
intentionally reductive for pragmatic reasons, reflecting the need to produce a coherent synthesis, whilst 
recognising that different philosophies underpinned the various approaches used
21
.  .   
The COREQ checklist
22
 was used for reporting on qualitative research and the GRIPP checklist
23
 for reporting 
on patient and public involvement in research.  
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Table 3. Methods used in Germany, Italy, The Netherlands and Lithuania. 
Methods Used Germany  ? lay 
stakeholders 
Germany ? 
Professionals 
Italy  ? lay 
stakeholders 
Italy  ? 
Professionals 
The Netherlands   ? lay 
stakeholders 
The Netherlands  - Professionals Lithuania  Professionals, including 
representatives of patient 
organisations 
Location:  A city & 2 small towns 
in northern Germany 
A city & 2 small towns 
in northern Germany 
 Rome (Lazio 
Region) & Lecce 
(Puglia Region) 
Rome (Lazio 
Region) & Lecce 
(Puglia Region) 
Nijmegen Nijmegen Kaunas 
Qualitative 
methodology used 
Qualitative research: nominal group technique and 
categorical coding procedure informed by a 
Grounded Theory approach. 
Qualitative research: using EUnetHTA Core 
Model®
14
as a framework. 
 
Qualitative research: Interactive evaluation and subsequently 
case reconstruction using constant comparison. 
Qualitative research & Thematic 
analysis. 
Sampling strategy  A mixture of convenience 
and purposeful sampling.   
The co-ordinator directly 
approached individual or 
organizations and asked 
palliative care experts in 
pre-informer 
consultations to identify 
important stakeholders. 
Professionals recruited 
patients and relatives. 
A mixture of 
convenience and 
purposive sampling, 
the co-ordinator 
directly approached 
individual or 
organizations. 
 
Convenience sampling  
Co-ordinator directly approaching 
individual or organizations. 
 
Co-ordinator directly 
approaching individual 
or organizations 
Physicians were asked 
to recruit patients. 
 
Purposeful sampling Co-ordinator 
directly approaching individual or 
organizations Professionals 
nominated other professionals 
working in the field of palliative 
who were willing to participate. 
Purposeful sampling  
Co-ordinator directly approaching 
individuals 
Total No. of Group 
/ individual 
meeting / both 
used 
4 Individual interviews 
with patients (n=4) and 1 
focus group separately 
with relatives (n=4).  
 
1 focus group 
separately with 
professionals (n=7). 
7 Individual 
interviews (n=8) 
8 Individual 
interviews (n=8) 
2 Individual interviews 
(n=2) 
12 Individual interviews (n=12)  W 
one professional was interviewed 
twice due to her expertise.  
2 focus groups and 1 individual 
interview (1x6, 1x2, 1x1) (n=9) 
Data collection: 
/ŶƚĞƌǀŝĞǁĞƌ ?Ɛ
relationship with 
participants 
Face-to-face interviews 
with patients & focus 
group with relatives (All 
audio recorded & notes 
taken). 
Focus group (All 
audio recorded & 
notes taken). 
 
Individual, face-to-face / telephone 
interviews (All audio recorded & notes 
taken). 
 
Face-to-face  interviews 
(Notes taken) 
Face-to-face interviews (Notes 
taken). Some were contacted by 
email post meeting for clarification 
of their responses. 
Face-to-face  interview & 2 focus groups 
(All audio recorded) 
 
Moderation cards were used and prioritization of 
points took place in the focus groups and in the 
interviews 
AD, KH & KM (all HTA researchers) at the time 
unknown to stakeholders, completed data 
collection. 
 
MDN (researcher in palliative care) at 
the time unknown to stakeholders, 
completed data collection. 
MT & GJvdW (HTA researchers) at the time unknown to half 
of the stakeholders, completed data collection. 
AB (palliative care researcher) known 
to most stakeholders, completed data 
collection. 
Location  W e.g. 
home office etc.  
In the patients´ home, a 
nursing home and at a 
palliative care unit. 
Focus group with relatives 
and professionals took 
place in the premises of 
the University of Bremen. 
The University of 
Bremen. 
 
Home The University or 
tŚĞƐƚĂŬĞŚŽůĚĞƌ ?Ɛ
workplace.  
Patients chose the 
location of the 
interview which were 
held in familiar 
surroundings (home / 
hospice). 
Radboud university medical center 
ŽƌĂƚƚŚĞƐƚĂŬĞŚŽůĚĞƌ ?ƐǁŽƌŬƉůĂĐĞ.  
Kaunas Nursing Hospital, Republican 
Hospital of Kaunas Palliative care unit & 
Oncology Hospital Palliative care unit. in 
Kaunas 
Length of interview 
/ meeting 
Interviews: 30-46 minutes  
Focus group relatives: 2.5 
3.5 hours 45min  W 60 min 
 
60 minutes approximately 
 
60 minutes 
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hours 
Methods used to 
analyse 
information / data  
Transcribed anonymised & open coding following 
Grounded Theory & nominal group technique 
 
 
Interviews transcribed anonymously & 
thematically analysed using key-words or 
key concepts within different domains. 
Presented in a  descriptive manner 
Reconstruction of interpretive frames 
 
Thematic analysis  - 
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&ŝŶĚŝŶŐƐ 
Stakeholders identified twenty three key issues that were common to three or more countries. These issues 
were categorised under four themes (see Table 5) to identify similarities in findings across different countries. 
Whilst word limits preclude presenting separate lay and professional findings in this paper, lay contributions 
ƉƌŝŵĂƌŝůǇƉƌŽǀŝĚĞĚŝŶƐŝŐŚƚƐŝŶƚŽƉĂƚŝĞŶƚƐ ?ĂŶĚĐĂƌĞƌƐ ?ĞǆƉĞƌŝĞŶĐĞƐŽĨƐĞƌǀŝĐĞƐǁŚĞƌĞĂƐƉƌŽĨĞƐƐŝŽŶĂůƐǁĞƌĞĂďůĞ
to draw on their experiences of service provision to a wide range of clients and situations. We used the issues 
ƚŽŝĚĞŶƚŝĨǇďŽƚŚĂŶŝŶƚĞƌǀĞŶƚŝŽŶĂŶĚĐŽŵƉĂƌĂƚŽƌŵŽĚĞůŽĨƐĞƌǀŝĐĞƉƌŽǀŝƐŝŽŶĨŽƌƚŚĞŵĂŝŶ,dƋƵĞƐƚŝŽŶ ?tĞĂůƐŽ
ƵƐĞĚƚŚĞŝƐƐƵĞƐƚŽŝŶĨŽƌŵƐƵďƋƵĞƐƚŝŽŶƐĨŽƌƚŚĞĂƐƐĞƐƐŵĞŶƚŽĨƐƉĞĐŝĨŝĐĂƐƉĞĐƚƐ ?Ğ ?Ő ?ĞƚŚŝĐĂů ?ƐŽĐŝŽ-ĐƵůƚƵƌĂů
ĂƐƉĞĐƚƐ ? ? dwo of the issues raised by stakeholders; the need to increase home care provision and for caregiver 
training/support resonated with the findings of a review of review level evidence about models of service 
provision that had been completed at the same time as the initial stakeholder involvement. (The review was 
undertaken to assist decision making about intervention and comparator models that could be used to test 
concepts and methods developed in the project within the palliative care case study). 
Insights from the evidence base and stakeholder views of the key issues in palliative care allowed us to select 
home based models of palliative care with and without an additional component of informal carer support as 
ƚŚĞĨŽĐƵƐĨŽƌƚŚĞĐĂƐĞƐƚƵĚǇ ?dŚĞƐĞŵŽĚĞůƐ ?ŬŶŽǁŶĂƐ ‘ƌĞŝŶĨŽƌĐĞĚ ?ĂŶĚ ‘ŶŽŶ-ƌĞŝŶĨŽƌĐĞĚ ?ŵŽĚĞůƐŽĨŚŽŵĞĐĂƌĞ24 
respectively, provided the intervention and comparator models for the main HTA research question. 
Reinforced models of home palliative care explicitly address two of the issues raised by stakeholders in several 
countries (i.e. the need for caregiver training/support and the need to increase home care). The remaining 
issues helped to sensitize the team to key issues in palliative care; assisted the development of sub questions 
(e.g. for the socio-cultural aspects which focused on the user-professional-relationship and decision making) 
and subsequently informed specific assessments (e.g. the ethical assessment) within the HTA. 
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Table 4. Background details of the stakeholders involved in each country. 
 Lay stakeholders Professional stakeholders 
 E n=20 G n=8 I n= 7 Ne n= 2 No n= 5 Pn= 8 L* E n=34 G n=7 I n=8 Ne n=12 No n=5  P n=7  L n=9* 
Location Sheffield  W a 
city in the 
North of 
England  
City & small 
town in 
northern 
Germany  
6 Rome 
(Lazio 
Region) 
1 Lecce 
(Puglia 
Region) 
Nijmegen  Oslo Bydgoszcz  Across 
England & 1 
from Ireland 
City & small 
town in 
northern 
Germany  
6 Rome (Lazio 
Region) 
1 Lecce 
(Puglia 
Region) 
Nijmegen  Oslo Bydgoszcz Kaunas 
Sex M -10 F-10  M-3 F-5 M-2   F-5 M-1      F-
1 
M-2      F-3 M-0      F-8  M-9      F25 M-1     F-6 M-3      F-5 M-6      F-6 M-1     F-4 M-4      F-3 F-9 
Age  ? range  
(mean)  
32-89  40-69 
 
33-72  
 
Did not 
ask 
27-81 
 
 
25-65 
 
 28-66  
  
40-69  33-67 Did not ask 50-59  
 
38-52 
 
28-66  
Advisor  
 
P-2 
P & C -1  
C W 2  
Ex-C- 2 
FM  W 6  
Fr -2  
PC group -5  
P-4 
FM  W 4  
 
FM  W7  
 
P-2 
 
P - 3 
C  W 2 
PC group - 3 
V - 5 
 
 Cl-22 
R  -6 
Cl & R - 5 
M -1 
Cl -4 + 1 
(retired) 
Cl& R  - 1  
M- 1  
 
Cl  W 4  
R  W 3  
V - 1  
Cl  W 6  
Cl& R  - 6  
 
Cl& R  W 5  
 
Cl  W 3  
Cl & R W 4  
 
Cl 6 (4 
managers) 
Cl& R  W 1  
SW & PCS 
 W 2  
 
 Ethnicity: White  - 19 
Asian W 
Indian  W 1  
No details 
available  
White  W 7  White  W 
2  
 
White  W 4  
Other Asian  W 
1  
White - 8  White-31 
African-2 
Caribbean - 1 
No data 
available  
 
White-8 
 
White-12  
 
White-5  
 
White-7  
 
White-9 
 
Religion: Christian  W 
13   
Hindu -1  
None / 
Neutral  W 3 
Non 
response - 3 
Catholic  W 2  
Protestant  W 
2  
None / 
Neutral  W 2  
Non 
response  W 2  
Catholic  W 
7  
Did not 
ask  
Christian  W 1  
Muslim  W 1  
None / 
Neutral  W 1  
Did not ask  W 
2  
Catholic  W 8  Christian  - 19  
Jewish 
None- 12  
3 (pilot) not 
asked 
Catholic 1  
Protestant  W 3  
Jewish  W 1  
2 preferred 
not to say  
Roman 
Catholics 8 
Not asked  Christian 3 
Not asked 
 W 2  
Catholics 7  Christian 9 
ǇĞĂƌ ?Ɛ ?
experience 
of palliative 
care: Range 
(Mean) 
1-26 years 
(8.86 (based 
on 15 
responses)  
All 4 
patients had 
less than 6 
ŵŽŶƚŚƐ ?
experience 
& relatives 
had 6 
months  W 3 
years 
1-
24months 
(5.1 
months 
based on 
7 
responses) 
- 2weeks  W  
approximately 
2 years  
3-20 (10) 
years based 
on 8 
responses 
 3 months-43 
years (18.8 
years based 
on 31 
responses) 
 
5-18 years (10 
years based 
on 7 
responses) 
2-15 (10 years 
based on 8 
responses) 
Not known Not known  4-25 (15 
years based 
on 7 
responses) 
15 
E: England; G: Germany; I: Italy; Ne: The Netherlands; No: Norway; P: Poland; L: Lithuania 
*In Lithuania, the professionals approached included 3 representatives of patient organisations provided information in lieu of approaching lay stakeholders for two reasons; 1) Patients receiving palliative care have a serious 
health condition and 2) palliative care in Lithuania is relatively new field and competent opinion can express may be more specialist.Lay stakeholders: P:Patient;  P&C: patient & carer; C: Carer;  Ex-C: Ex Carer;  FM: Family 
member ; Fr: Friend; PC Group : Member of palliative care group / associations; V: volunteers (among lay stakeholders in Poland).  Professional stakeholders: Cl: Clinicians; R: Researchers; Cl & R: Clinician & Researcher (dual 
role); M: Manager, SW & PCS: Social worker and Pastoral Care Specialist; V: volunteers (among professional stakeholders in Italy).   
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Table 5. Common Issue identified by stakeholders across seven countries (England, Germany, Italy, The Netherlands, Norway, Lithuania & Poland). 
Countries  Common Issue identified by stakeholders 
 Theme 1: knowledge and understanding   
Information about issues related to the knowledge and understanding of palliative care were clustered within this theme. 
E, G,  I, L,  Ne, No, P /ŵƉƌŽǀĞƉƌŽĨĞƐƐŝŽŶĂů ?ƐĂďŝůŝƚǇƚŽƌĞĐŽŐŶŝƐĞƉĂƚŝĞŶƚƐǁŝƚŚƉĂůůŝĂƚŝǀĞcare needs & transition to palliative care. 
 
E, G,  I, L,  Ne, No, P Ensure practitioners are adequately trained to deliver palliative care including providing support for generalists providing palliative care. 
 
E, G,  I, L,  No, P Improve understanding of the definition & nature of palliative care by professionals, patients and the public / society. 
E, I, L,  Ne, P Reduce stigma of death and palliative care in society 
 
E, I, L, No, P Develop greater understanding (for professionals, patients and the public) about harms, & reduce, physical, psychological, social & economic harms for patients (e.g side 
effects of treatments/ medicalization of dying), families (e.g. stress of caring / bereavement / economic problems)  & staff (e.g. burnout). 
  
E, I, L, P Provide training and support for family carers.  
 
E, G,  I, L,  No, P Identify what effectiveness means for palliative care services (QoL, symptom control are the focus for effectiveness ). 
 
E, L, No Improve patient and carer understanding of ethical issues (e.g. discontinuation of futile treatments). 
 
E, G, I 
 
/ŶĐƌĞĂƐĞƉĂƚŝĞŶƚƐ ? ?ĐĂƌĞƌƐ ?ĂŶĚƉƌŽĨĞƐƐŝŽŶĂůƐ ?ƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨĂƌĂŶŐĞŽĨůĞŐĂůŝƐƐƵĞƐƌĞůĂƚŝŶŐƚŽƉĂůůŝĂƚŝǀĞĐĂƌĞ ?Ğ ?Ő ?the right to live or die, euthanasia, safeguarding, 
ĐĂƉĂĐŝƚǇ ?ĂĚǀĂŶĐĞĚĚŝƌĞĐƚŝǀĞƐ ?ƉĂƚŝĞŶƚ ‘ƐĂƵƚŽŶŽŵǇ ? ? 
 
E, G, I, L Develop an understanding of how different social & cultural backgrounds of patients and staff influence the provision of palliative care. 
 
 Theme 2: organisational dependent availability and access  
Information about issues related to the availability and access to palliative care were clustered under this theme. 
E, G,  I, L,  No, P Increase availability of palliative care W e.g. increase bed numbers & service to all disease types, more patients  Welderly MH LD  & in a variety of geographical and care 
settings  W e.g. rural areas / nursing homes / home. 
 
E, G,  I, L,  No, P Enhance recognition of palliative care as a speciality. 
 
E, G,  I, L,  Ne, No, P Funding of palliative care requires attention (to ensure funding continues or to reduce costs). 
E, G,  I, L,  No, P Equity of access to palliative care is a concern due to availability of palliative care, specific professions and eligibility criteria. 
 
E, G,  I,  No, P Ensure easy (e.g. out of hours),equitable (e.g. to all groups)  and timely (e.g. not restricted only to the last months of life) access to palliative care. 
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E, G,  I, L,  No, P Possible over-treatment (if death seen as a defeat by professionals) or under-treatment (because of failure to identify palliative care needs). 
 
E, I, No, P Improve availability of specific disciplines within the palliative care  W eg dieticians, psychologists, Occupational therapists, music therapists. 
E, G, I, P Provide support for family carers post bereavement. 
 
 
 
Theme 3: attitudes and clinical decision-making  
Information about issues such as communication which reflect attitudes and affect decision making. 
E, G,  I, L,  No, P Need for information Wgiving to patients and carers about a range of issues to improve patient decision making and autonomy. 
E, G,  I, Ne, No Communication recognised as important  W  
Overcome communication difficulties with patients and carers (e.g. re prognosis, to avoid deception & to ensure informed consent). 
 
 
 
Theme 4: continuity of care (outcome which is dependent of the three above preconditions)  
Information about issues influencing the continuity of care both at an organisational and individual level were included in this theme. 
E, G,  I, L,  Ne, No, P Improve the organisation of palliative care in terms of co-ordination of, communication & co-operation between services to ensure continuity of patient care. 
 
E, G,  I, Ne, No Withdrawal of treatment & the transition from active to palliative care is an area of concern. 
 
E, I, No, P Reduce hospitalisation and increase home care. 
 
E: England; G: Germany; I: Italy; Ne: The Netherlands; No: Norway; P: Poland; L: Lithuania 
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Discussion 
Despite ĚŝĨĨĞƌĞŶĐĞƐŝŶƉĂůůŝĂƚŝǀĞĐĂƌĞƉƌŽǀŝƐŝŽŶƚŚƌŽƵŐŚŽƵƚƵƌŽƉĞ ?ĂŶĚƚŚĞƵƐĞŽĨǀĂƌŝŽƵƐlocally sensitive ĐŽŶƐƵůƚĂƚŝŽŶ
ŵĞƚŚŽĚƐ ?stakeholders in seven European countries identified common issues ŝŶƉĂůůŝĂƚŝǀĞĐĂƌĞ ?^ƚĂŬĞŚŽůĚĞƌƐ ? advice 
informed the project in several ways, notably enhancing our understanding of palliative care and enabling the team to 
select  ‘ƌĞŝŶĨŽƌĐĞĚ ?ĂŶĚ ‘ŶŽŶ-ƌĞŝŶĨŽƌĐĞĚ ?models of home based palliative care24 as the intervention and comparator of 
interest for the application of the HTA methods developed in the project. Additionally, stakeholder involvement 
sensitized the team to key issues in palliative care  (e.g. the philosophy of palliative care re patient and caregiver as a 
unit of care; patient preferences of home care/death which is reflected in Policy initiatives to increase availability of 
home palliative care/home death across several countries involved in the project). As a result, stakeholder 
involvement also subsequently informed sub questions and specific assessments within the HTA (e.g. the ethical and 
socio-cultural assessments). 
We learned that both lay and professional stakeholders can contribute much experiential knowledge of palliative 
care, assisting project development.  Involving stakeholders required consideration of their needs for access, support; 
appropriate project information and questioning in a manner that enhanced their confidence in providing information 
/ data. The methodological, ethical and practical issues for stakeholder involvement in palliative care research vary 
between countries. There is no recommended approach to stakeholder involvement and, although clear 
methodologies exist when using qualitative research approaches, this is not the case for stakeholder consultation. 
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knowledge and has a different role to that of other types of evidence. Hence, as Sharma et al (2015)
25
 suggest, this 
type of knowledge should not be judged in the same way as other evidence because it is not collected in the same 
rigorous and systematic manner.   
Whilst no consensus exists about the best methods of stakeholder consultation
13
, by using locally sensitive methods 
of stakeholder involvement, we ensured that a variety of stakeholder perspectives of palliative care were integrated 
into the project design. This adds to the body of evidence that stakeholders, including patients and the public, can 
assist in designing research
9
 which changes their roles and relationships with researchers
26
. Given the different 
stakeholder roles and relationships with researchers, we had to overcome uncertainty about ethical requirements 
which vary in each country when undertaking stakeholder involvement, especially when using a consultation 
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approach. Furthermore, systematic methods for identifying common topics proved challenging, although similar 
issues arose across countries.  
Despite interest in palliative care amongst European policy makers
27
, there has been a lack of international 
comparative perspectives on service developments
28
. Differences in the amount and source of data and the 
difficulties of cross country comparative analysis have previously been recognised
27
. However, including the 
perspectives of patients and the public adds a new dimension to these complexities.  
 
Strengths and limitations 
Involving stakeholders early in project development in seven European countries was a major strength as it assisted 
the identification of issues that were common across countries. This provides  ‘added value ? as it enhances the 
likelihood of the findings having international relevance. However, whilst using different methods of stakeholder 
involvement was a strength in terms of being locally appropriate, it proved challenging in terms of synthesis. 
Limitations exist in the reporting of differences in professional and lay perspectives across countries. Almost all 
stakeholders were white Christians which limits identification of the views of ethnic minority groups who are known 
to have specific palliative care needs
29
.   
Conclusion 
There are no gold standard approaches for stakeholder involvement across Europe. However our findings indicate this 
can be done successfully in a variety of different ways, using a variety of different approaches/methods. Researchers 
should consider ƵŶĚĞƌƐƚĂŶĚŝŶŐƐĂďŽƵƚƐƚĂŬĞŚŽůĚĞƌŝŶǀŽůǀĞŵĞŶƚŝŶƚŚĞůŽĐĂůĐŽŶƚĞǆƚ when undertaking this in more 
than one country as ƐŽŵĞĂƉƉƌŽĂĐŚĞƐ ?ŵĞƚŚŽĚƐŵĂǇďĞĐŽŶƐŝĚĞƌĞĚŵŽƌĞĂƉƉƌŽƉƌŝĂƚĞƚŚĂŶŽƚŚĞƌƐ ? Although it may 
not be straightforward, it is both feasible and worthwhile to invest in palliative care stakeholder consultation when 
undertaking research. Irrespective of the method used, the added value of international stakeholder involvement is 
evident.  Stakeholder involvement ĞŶŚĂŶĐĞĚƚŚĞƉƌŽũĞĐƚƚĞĂŵ ?ƐƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨŝƐƐƵĞƐŝŶƉĂůůŝĂƚŝǀĞĐĂƌĞƚŚĂƚǁĞƌĞ
common across countries.^ƚĂŬĞŚŽůĚĞƌŝŶĨŽƌŵĂƚŝŽŶĐĂŶŝŶĨŽƌŵƉƌŽũĞĐƚĚĞĐŝƐŝŽŶŵĂŬŝŶŐ about both the intervention 
and comparator used in the main HTA research question and the focus of sub questions used to assess other aspects 
in the project.  Such widespread stakeholder involvement potentially enhances the applicability of the project 
findings.  Methods for stakeholder involvement need further development,  especially with reference to stakeholder 
consultation and synthesis of information from the different approaches that can be used. 
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